|
From CRP to IL-6 to IL-1: Moving Upstream To Identify Novel Targets for Atheroprotection
|
5
|
Resverlogix Corp.
|
May 11, 2019 04:06PM
|
|
Re: Albuminuria
|
5
|
Resverlogix Corp.
|
Dec 02, 2019 08:04PM
|
|
Re: From the NKF Facebook Page...
|
5
|
Resverlogix Corp.
|
Feb 25, 2020 12:26PM
|
|
Re: DM Interview w Jane King (Innovators) Apr 7 - COVID 19
|
5
|
Resverlogix Corp.
|
Apr 09, 2020 09:30AM
|
|
Re: Today's wrap...my view
|
5
|
Resverlogix Corp.
|
Jun 12, 2019 07:36PM
|
|
ZEN-3694 the first pan-BET inhibitor in Phase 3?
|
5
|
Zenith Epigenetics
|
Oct 25, 2019 09:48AM
|
|
Re: ESC Poster on Vascular Inflammation, Calcification and Plaque Vulnerability
|
5
|
Resverlogix Corp.
|
Sep 03, 2019 12:08PM
|
|
ASN Abstracts
|
5
|
Resverlogix Corp.
|
Oct 11, 2019 03:21PM
|
|
Re: Marching on to March events
|
5
|
Zenith Epigenetics
|
Feb 15, 2018 04:30PM
|
|
Re: Making a "big deal" out of November 15
|
5
|
Resverlogix Corp.
|
Nov 14, 2016 10:34AM
|
|
Re: Sparks Therapeutics Gene Therapy Deal
|
5
|
Resverlogix Corp.
|
Feb 24, 2019 03:23PM
|
|
Re: No doubt about it....
|
5
|
Resverlogix Corp.
|
Jun 03, 2019 07:57AM
|
|
Any catalysts in Q1 to awaken the masses?
|
5
|
Resverlogix Corp.
|
Jan 19, 2016 09:55PM
|
|
Re: What impact would a PR like this have?
|
5
|
Resverlogix Corp.
|
Jan 29, 2019 01:05PM
|
|
Re: La vie en rose.....
|
5
|
Resverlogix Corp.
|
Sep 15, 2017 02:30PM
|
|
Re: Anacetrapib Officially Bites the Dust
|
5
|
Resverlogix Corp.
|
Oct 12, 2017 11:01AM
|
|
Re: Zenith Epigenetics Announces Dosing of First Patient in Triple Negative Breast Cancer Trial with Pfizer
|
5
|
Zenith Epigenetics
|
Oct 25, 2019 09:59AM
|
|
Re: Marching on to March events
|
5
|
Zenith Epigenetics
|
Feb 15, 2018 04:38PM
|
|
Re: FDA phase 3 approval (s)
|
5
|
Resverlogix Corp.
|
Feb 11, 2016 01:12PM
|
|
Re: eGFR and Cognition?
|
5
|
Resverlogix Corp.
|
Nov 22, 2019 08:14PM
|
